Skip Navigation LinksHome > May/June 2009 - Volume 33 - Issue 3 > Bisphosphonate-Related Osteonecrosis of the Mandible and Max...
Journal of Computer Assisted Tomography:
doi: 10.1097/RCT.0b013e318186b179
Musculoskeletal Imaging

Bisphosphonate-Related Osteonecrosis of the Mandible and Maxilla: Clinical and Imaging Features

Gill, Sonia B. MD*; Valencia, Maria P. MD*; Sabino, Mary Lou C. DDS†; Heideman, Gregory M. MD*; Michel, Michelle A. MD*

Collapse Box


Objective: Bisphosphonate-related osteonecrosis of the jaws is a rare, but morbid, condition. We present the clinical and imaging features of 19 patients.

Methods: A review of 19 bisphosphonate-related osteonecrosis patients was performed. Patient demographics, diagnosis, dental procedures, symptoms and clinical findings, location and pattern of involvement, and presence of fractures, sequestra, and fistulae were documented.

Results: Patients included 14 women and 5 men aged 48 to 80 years. Diagnoses included breast carcinoma (n = 11), multiple myeloma (n = 4), osteoporosis (n = 4), prostate carcinoma (n = 2), and lymphoma (n = 1). Seventeen patients received intravenous and 2 received oral bisphosphonates for 2 to 5 years. Bone involvement was noted in the mandible (74%), maxilla (16%), and both (10%). A lytic and sclerotic pattern was most common (58%). Additional findings included fractures (n = 5), sequestra (n = 4), and oroantral fistulae (n = 2).

Conclusions: Bisphosphonate-related osteonecrosis is a rare, but morbid, condition, and imaging features can mimic other conditions. It is important for the radiologist to consider this entity in the appropriate clinical setting.

© 2009 Lippincott Williams & Wilkins, Inc.



Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.